[Federal Register Volume 89, Number 43 (Monday, March 4, 2024)]
[Notices]
[Pages 15579-15580]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-04433]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Meeting of the Mine Safety and Health Research Advisory Committee

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the 
Centers for Disease Control and Prevention (CDC) announces the 
following meeting of the Mine Safety and Health Research Advisory 
Committee (MSHRAC). This is a hybrid meeting, accessible both in person 
and virtually. It is open to the public and limited only by the space 
available and the number of web conference lines available. Time will 
be available for public comment.

DATES: The meeting will be held on April 17, 2024, from 8:30 a.m. to 
4:10 p.m., EDT.

ADDRESSES: Mine Safety and Heath Administration's Approval and 
Certification Center, 765 Technology Drive, Triadelphia, West Virginia 
26059. The conference room accommodates approximately 49 people.
    Please note that the meeting location is a Federal facility and in-
person access is limited to U.S. citizens unless prior authorizations, 
taking up to 30 to 60 days, have been made.
    If you wish to attend the meeting either in person or virtually, 
please contact Ms. Berni Metzger by email at [email protected] or by 
phone at (412) 386-4541 at least 5 business days in advance of the 
meeting. If you are attending virtually, she will provide you with the 
Zoom web conference access information (500 web conference lines are 
available).

FOR FURTHER INFORMATION CONTACT: Steven Mischler, Ph.D., Designated 
Federal Officer, Mine Safety and Health

[[Page 15580]]

Research Advisory Committee, National Institute for Occupational Safety 
and Health, Centers for Disease Control and Prevention, 626 Cochrans 
Mill Road, Pittsburgh, Pennsylvania 15236. Telephone: (412) 386-5688; 
Email: [email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The Mine Safety and Health Research Advisory Committee is 
charged with providing advice to the Secretary, Department of Health 
and Human Services; the Director, Centers for Disease Control and 
Prevention; and the Director, National Institute for Occupational 
Safety and Health (NIOSH), on priorities in mine safety and health 
research, including grants and contracts for such research, 30 U.S.C. 
812(b)(2), Section 102(b)(2).
    Matters To Be Considered: The agenda will include discussions on 
NIOSH mining safety and health research organizational structure, 
capabilities, projects, and outcomes, as well as a verbal report from 
the Mace Development Workgroup. The meeting will also include an update 
from the NIOSH Associate Deputy Director, Mine Safety and Research. 
Agenda items are subject to change as priorities dictate.

Public Participation

    Written Public Comment: The public may submit written comments or 
questions in advance of the meeting, to the Designated Federal Officer 
(see FOR FURTHER INFORMATION CONTACT above). Written comments received 
in advance of the meeting will be included in the official record of 
the meeting, and questions will be answered during the oral comment 
period open to public participation.
    Oral Public Comment: The meeting will include time for members of 
the public to make an oral comment. The public comment session will be 
held on April 17, 2024, at 3:30 p.m., EDT, or the conclusion of the 
planned presentations, whichever comes first. Members of the public 
will be allocated 5 to 10 minutes each for presentations or comments, 
as a function of the number of commenters.
    The Director, Office of Strategic Business Initiatives, Office of 
the Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-04433 Filed 3-1-24; 8:45 am]
BILLING CODE 4163-18-P